A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
about
Network biomarkers reveal dysfunctional gene regulations during disease progressionComparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerInorganic Arsenic-induced cellular transformation is coupled with genome wide changes in chromatin structure, transcriptome and splicing patternsAn RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancerMicrofibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivoAngiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerIdentification of novel therapeutic targets in microdissected clear cell ovarian cancersMeta-analytical biomarker search of EST expression data reveals three differentially expressed candidates.curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeMás-o-menos: a simple sign averaging method for discrimination in genomic data analysis.Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators.Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancerBET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.A network module-based method for identifying cancer prognostic signaturesNetwork-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.Similarity of markers identified from cancer gene expression studies: observations from GEOHTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemiaWnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.Semi-supervised learning improves gene expression-based prediction of cancer recurrence.Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancersPTN signaling: Components and mechanistic insights in human ovarian cancer.Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors.ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approachesMultidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinomaIdentification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaCharacterization of the Expression of the RNA Binding Protein eIF4G1 and Its Clinicopathological Correlation with Serous Ovarian CancerElevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modulesOverexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance.
P2860
Q26824601-1D4D63CC-29AE-4D75-BF4D-3D76EF0E59B5Q26859166-6E7A1312-4B4F-4384-984D-618853170C1EQ28390396-2954094A-0F74-4093-939F-5C41E85F740EQ28484295-584FAC9B-E032-40CB-B0A3-F4D4F549190AQ28584810-D852BB8A-FD83-489B-9E4E-8035C37B4627Q28732124-37038E95-1947-404E-8226-C3CBB1F9E381Q28742873-8E74452F-4C3C-4F65-80D0-CF4DA24DE8ECQ30584141-DBA41779-96A8-4ADB-B2D9-C845344F99F9Q30611147-DE44EFDE-39AC-4DB8-825A-BD282DA8EB23Q30838620-8863BBB6-7EBB-44D8-9717-450805496A7DQ33595061-B3110ADC-4C72-4C21-9D6B-EF1844BF9B2AQ33762434-35B05ABB-A4D2-48AA-9532-EB315E90CC2CQ33890351-727952AA-37C7-4A82-9BE6-9ADA8DF3AB24Q34047394-68176712-4F67-4758-9CBA-2C725CA94ABDQ34137275-D96EB45A-DEC3-433E-87F1-F70BACC08705Q34276961-521354AA-BDFC-4FFB-8924-9E55E0A0CA72Q34290146-F542AB8D-11B6-435B-89F0-1DE2BFE7CD17Q34447404-E34C8C6E-D3E7-49F0-968F-1075373A7C9CQ34514528-C5992E5C-8D6D-4F0D-BA54-82C96D1DDD66Q34646243-94F2FB7B-D7F2-4639-A038-7E13BF731A76Q34649455-4AF51522-287B-46CC-8EE0-218C73C9F903Q34662610-1B0D18E8-C220-46A9-B38B-BC6DFD26D0BFQ34674610-F5C0C80D-07DA-4AF7-8C38-0E2DDB50284DQ34736426-AB7C7624-53B8-4105-AF2E-B34AA8070E51Q34941861-07983C7C-DC15-46FE-8C35-93CA3B7B24E3Q35256323-E5A10587-F062-4788-95AD-3DC595FD162FQ35411665-DED26754-AA3B-45B6-AA9E-C9BA4519E301Q35600924-40F31B7B-CD05-43D5-B476-8771EE7600EBQ35685365-0A020367-A34C-4915-9A04-441AD1EE7EC6Q35750824-0F458B3C-DE25-4A45-9FEA-67BEDA548BCBQ35803467-8BDD900A-7A36-4D47-A302-99B1A1A2D34DQ36037099-7A7FF163-FCA2-4444-A30E-E78228BE7C5BQ36075250-E2C77D22-1B7B-430C-AAC4-1D5D927EA053Q36087199-D21026A0-97D2-4B2C-A818-6216E2E9903DQ36103829-CACC78B5-EA6A-43ED-8E7C-48EAE47F9F62Q36144493-EA4CE63E-C287-40BF-B04B-826B2464A559Q36182116-CF2B161A-9E78-4F87-820A-4C09D3DCC3B1Q36206487-7EDCEA4F-4181-494E-B755-1A1AB29515EAQ36275831-F02BDB17-879E-4909-AD7E-FEC8FD91D41FQ36286844-DCFC54A7-8E32-47EC-9AF3-CCA4443BE388
P2860
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@ast
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@en
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@nl
type
label
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@ast
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@en
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@nl
prefLabel
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@ast
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@en
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@nl
P2093
P2860
P1433
P1476
A gene signature predictive fo ...... ril-associated glycoprotein 2.
@en
P2093
Aaron Bell
Cindy A Pise-Masison
Daniel K P Yip
Dong-Choon Park
Goli Samimi
Howard Donninger
J Carl Barrett
John Brady
Kwong-kwok Wong
P2860
P304
P356
10.1016/J.CCR.2009.10.018
P577
2009-12-01T00:00:00Z